20th Anniversary
Membership
- Current Members
Initiatives
Advocacy
About
RBQM Summary Report

Health Canada Guidance: Applications for drug clinical trials under the Interim Order

June 2, 2020 By Natalia Gonzalez

Previous Article

National Medical Product Administration Blogpost: Research well underway into COVID-19 vaccines and drugs, premier says

Next Article

Food and Drug Administration Guidance: COVID-19: Developing Drugs and Biological Products for Treatment or Prevention

Recent Posts

ACRO Announces 2023 Officers and New Member
ACRO Expands Decentralized Clinical Trials Toolkit with Release of Change Management Resource
ACRO & TransCelerate Issue a Joint Statement on Considerations while Developing Clinical Study Reports (CSRs)
ACRO Releases Diversity and Inclusion Principles Statement in Support of More Diverse Clinical Trials
OPINION: Keep Our Foot on the Gas for Clinical Trial Diversity

About ACRO

The Association of Clinical Research Organizations (ACRO) and its members collaborate in pursuit of a global regulatory and business environment that fosters efficient, effective & safe clinical research.

Subscribe

Get in Touch

601 New Jersey Ave NW, #350,
Washington DC 20001
info@acrohealth.org
+1 (202) 464-9340

© ACRO 2021